Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-beta 1 in normal rat kidney (NRK) cells: decreased PAI-1 expression in transformed NRK cells

Endocrinology. 1990 Jun;126(6):2936-46. doi: 10.1210/endo-126-6-2936.

Abstract

Type 1 transforming growth factor-beta (TGF beta 1) was found to be a potent inducer of the secretion of a 49,000 mol wt protein by normal rat kidney (NRK) cells. This protein was related to type 1 plasminogen activator inhibitor (PAI-1) on the basis of molecular mass, activity in the presence of sodium dodecyl sulfate, immunoprecipitation by antibodies to PAI-1, and N-terminal sequence analysis. PAI-1 levels in the conditioned medium of NRK cells were increased 5- to 11-fold when cells were incubated with picomolar concentrations of TGF beta 1 for 24 h, reaching a concentration of approximately 0.3 microgram/ml. The secreted PAI-1 was deposited in the NRK extracellular matrix as well as released into the culture medium. A spontaneously transformed NRK cell line was found to secrete 3-4 times less PAI-1, in the absence or presence of TGF beta 1, compared to the parent cell line, while PAI-1 secretion in Kirsten sarcoma virus-transformed NRK cells was almost completely abrogated. A novel purification procedure was established, which results in the isolation of highly active and detergent-free TGF beta 1-induced PAI-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cell Line
  • Cell Transformation, Viral*
  • Dactinomycin / pharmacology
  • Dose-Response Relationship, Drug
  • Extracellular Matrix / metabolism
  • Immunosorbent Techniques
  • Kidney / metabolism*
  • Kinetics
  • Kirsten murine sarcoma virus
  • Molecular Sequence Data
  • Molecular Weight
  • Plasminogen Inactivators / isolation & purification
  • Plasminogen Inactivators / metabolism*
  • Rats
  • Sodium Dodecyl Sulfate / pharmacology
  • Transforming Growth Factors / administration & dosage
  • Transforming Growth Factors / pharmacology*

Substances

  • Plasminogen Inactivators
  • Dactinomycin
  • Sodium Dodecyl Sulfate
  • Transforming Growth Factors